We supply RMs with product information sheets and safety data sheets.
Reference materials catalogue
Category | Description | NMI Reference | Unit of issue in mg | Domestic Cost (A$ excl GST) | International Cost (A$) | Certificate |
---|---|---|---|---|---|---|
1-Androstendione | 1-Androstendione (5α-Androst-1-en-3,17-dione) * |
D845 | 1 | 207 | 290 | |
Danazol metabolites, Danazol metabolites | 2α-Hydroxymethylethisterone* |
D920 | 1 | 110 | 154 | |
WADA PCC, Nandrolone metabolites | 19-Noretiocholanolone sulfate (Na salt)* |
D849 | 1 | 110 | 154 | |
WADA PCC, Nandrolone metabolites | 7a-methylnandrolone |
S048 | 1 mg | 110 | 154 | |
Finasteride metabolites | Carboxy finasteride† |
S045 | 1 | 110 | 154 | |
4-Hydroxy steroids | 4-Hydroxy-estr-4-en-3,17-dione |
S043 | 1 | 110 | 154 | |
Steroids, Sports doping control, WADA PCC, 4-Hydroxy steroids | 1,6,7-d3-4-Hydroxyandrostendione |
S046 | 0.2 | 110 | 154 | |
17a-Methylclostebol metabolite | 17α-Methyl-4-chloroandrost-4-ene-3α,17β-diol |
S044 | 1 | 110 | 154 | |
WADA PCC, Methyldienolone | Methyldienolone† |
D916 | 1 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | Norbolethone |
D825 | 1 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | 13β,17α-Diethyl-5β-gonane-3α, 17β-diol (major metabolite)* |
D818 | 1 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | 13β,17α-Diethyl-5α-gonane-3α, 17β-diol (minor metabolite)* |
D820 | 1 | 110 | 154 | |
WADA PCC, Oral Turinabol metabolite | 6β-Hydroxy-oral turinabol† |
D615 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | d4-5α-Androstan-3α, 17β-diol-17-O- β-glucuronic acid |
S009 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D4-5α-Androstan-3α,17β-diol-3-O-β-glucuronic acid* |
S010 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D3-5β-Androstan-3α,17β-diol-17-O-β-glucuronic acid* |
S011 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D5-5β-Androstan-3α,17β-diol-3-O-β-glucuronic acid* |
S012 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | d4-Epitestsosterone-17-O-β-glucuronic acid |
S023 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D5-Etiocholanolone-3-O-β-glucuronide sodium salt* |
S020 | 1 | 110 | 154 | |
WADA PCC, 1-Testosterone* | 5α-Androst-1-ene-3α-ol-17-one* |
D832 | 0.2 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3α-5-Cyclo-5α-androstane-6β-ol-17-one |
S039 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 16α-Hydroxyandrosterone |
D843 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 6β-Hydroxyetiocholanolone |
D867 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 4β-Hydroxy DHEA* |
D834 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 7-Keto DHEA* |
D833 | 10 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 7α-HydroxyDHEA |
D875 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 16β-Hydroxy DHEA* |
D844 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3α-Hydroxyestrenone |
D873 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3β-Hydroxy-4-estren-17-one* |
D866 | 1 | 110 | 154 | |
Prohormones and metabolites, WADA PCC, Prohormones and metabolites | 7β-Hydroxy DHEA |
D865 | 1 | 110 | 154 | |
WADA PCC, REV-ERB agonist SR9009 metabolites | N-[(4-Chlorophenyl)methyl]-5-nitro-2-thiophenemethanamine hydrochloride† |
D1066 | 1 | 110 | 154 | |
WADA PCC, REV-ERB agonist SR9009 metabolites | Ethyl N-(5-nitro-2-methylthiophene)-3-aminomethylpyrrolidine-1-carboxylate† |
D1067 | 1 | 110 | 154 | |
WADA PCC, Stimulants | Formoterol fumarate† |
D1065 | 25 | 110 | 154 | |
WADA PCC, Stimulants | Higenamine hydrochloride† |
D1070 | 25 | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5α-androstan-3β-ol acetate (d13CVPDB / ‰ -32.00 ± 0.09), 5α-androstan-3α-ol-17-one acetate (d13CVPDB / ‰ -32.58 ± 0.03), 5β-androstan-3α-ol-11,17-dione acetate (d13CVPDB / ‰ -16.50 ± 0.03), and 5α-cholestane (d13CVPDB / ‰ -24.90 ± 0.05) † |
CU-PCC 33-2 | See certificate | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5β-androstan-3α-ol-17-one (d13CVPDB / ‰ -28.75 ± 0.01), 5α-androstan-3α-ol-17-one (d13CVPDB / ‰ -26.74 ± 0.03), 5β-pregnan-3α, 20a-diol (d13CVPDB / ‰ -18.65 ± 0.03) † |
CU-PCC 34-3 | See certificate | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one (d13CVPDB / ‰ -27.09 ± 0.07) † |
CU-PCC 40-1 | See certificate | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one acetate (d13CVPDB / ‰ -32.82 ± 0.02)† |
CU-PCC 41-1 | See certificate | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5α-cholestane (d13CVPDB / ‰ -25.03 ± 0.01) † |
CU-PCC 42-1 | See certificate | 110 | 154 | |
Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one acetate (d13CVPDB / ‰ -32.73 ± 0.06), 5β-androstan-3α, 17β-diacetate (d13CVPDB / ‰ -30.19 ± 0.07), 5α-cholestane (d13CVPDB / ‰ -24.83 ± 0.13), and 5β- pregnan-3α, 20a-diacetate (d13CVPDB / ‰ -21.16 ± 0.08) † |
CU-PCC 44-1 | See certificate | 110 | 154 | |
WADA PCC, Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon Isotope Delta Value of Boldenone* (d13CVPDB / ‰ –30.38 ± 0.29) |
MX020 | See certificate | 240 | 336 | |
WADA PCC, Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon Isotope Delta Value of Formestane* (d13CVPDB / ‰ –30.71 ± 0.48) |
MX021 | See certificate | 240 | 336 | |
WADA PCC, Nandrolone metabolites | 19-Noretiocholanolone sulfate (Na salt)* |
D849 | 1 | 110 | 154 | |
WADA PCC, Methyldienolone | Methyldienolone† |
D916 | 1 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | Norbolethone |
D825 | 1 | 110 | 154 | |
WADA PCC, Oral Turinabol metabolite | 6β-Hydroxy-oral turinabol† |
D615 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | d4-5α-Androstan-3α, 17β-diol-17-O- β-glucuronic acid |
S009 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D4-5α-Androstan-3α,17β-diol-3-O-β-glucuronic acid* |
S010 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D3-5β-Androstan-3α,17β-diol-17-O-β-glucuronic acid* |
S011 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D5-5β-Androstan-3α,17β-diol-3-O-β-glucuronic acid* |
S012 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | d4-Epitestsosterone-17-O-β-glucuronic acid |
S023 | 1 | 110 | 154 | |
WADA PCC, Testosterone metabolites (including internal standards) | D5-Etiocholanolone-3-O-β-glucuronide sodium salt* |
S020 | 1 | 110 | 154 | |
WADA PCC, 1-Testosterone* | 5α-Androst-1-ene-3α-ol-17-one* |
D832 | 0.2 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3α-5-Cyclo-5α-androstane-6β-ol-17-one |
S039 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 16α-Hydroxyandrosterone |
D843 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 6β-Hydroxyetiocholanolone |
D867 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 4β-Hydroxy DHEA* |
D834 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 7-Keto DHEA* |
D833 | 10 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 7α-HydroxyDHEA |
D875 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 16β-Hydroxy DHEA* |
D844 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3α-Hydroxyestrenone |
D873 | 1 | 110 | 154 | |
WADA PCC, Prohormones and metabolites | 3β-Hydroxy-4-estren-17-one* |
D866 | 1 | 110 | 154 | |
WADA PCC, Anti-inflammatory metabolites | α-Hydroxycarprofen† |
D1072 | 5 | 110 | 154 | |
WADA PCC, REV-ERB agonist SR9009 metabolites | N-[(4-Chlorophenyl)methyl]-5-nitro-2-thiophenemethanamine hydrochloride† |
D1066 | 1 | 110 | 154 | |
WADA PCC, REV-ERB agonist SR9009 metabolites | Ethyl N-(5-nitro-2-methylthiophene)-3-aminomethylpyrrolidine-1-carboxylate† |
D1067 | 1 | 110 | 154 | |
WADA PCC, Stimulants | Formoterol fumarate† |
D1065 | 25 | 110 | 154 | |
WADA PCC, Stimulants | Higenamine hydrochloride† |
D1070 | 25 | 110 | 154 | |
WADA PCC, Steroid Matrix Reference Material | 19-Norandrosterone* (221.4 ng/g) in 1,2-dimethoxyethane (1 mL) |
MX003 | See certificate | 165 | 242 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Value of 19-norandrosterone in Water containing 20% Methanol 1 (mL) * d13CVPDB / ‰ –29.7 ± 0.8 |
MX016 | See certificate | 240 | 336 | |
WADA PCC, Steroid Matrix Reference Material | Mass fraction of testosterone metabolites in freeze dried human urine*: 5α-androstane-3α-17β-diol (41.2 ± 1.8 ng/g), 5β‑androstane-3α-17β-diol (66.0 ± 2.9 ng/g), androsterone 1652 ± 29 ng/g), etiocholanolone (1359 ± 34 ng/g), testosterone (88.1 ± 4.2 ng/g), epitestosterone (21.9 ± 1.0 ng/g), T/E mass ratio (4.03 ± 0.26) |
MX017(i) | See certificate | 360 | 504 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Values: |
MX018 | See certificate | 240 | 336 | |
Nandrolone and metabolites, Nandrolone and metabolites, WADA PCC, Nandrolone and metabolites | Epinandrolone sulfate TEA salt |
D783 | 5 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | 13β,17α-Diethyl-5β-gonane-3α, 17β-diol (major metabolite)* |
D818 | 1 | 110 | 154 | |
Norbolethone and metabolites, WADA PCC, Norbolethone and metabolites | 13β,17α-Diethyl-5α-gonane-3α, 17β-diol (minor metabolite)* |
D820 | 1 | 110 | 154 | |
Prohormones and metabolites, WADA PCC, Prohormones and metabolites | 7β-Hydroxy DHEA |
D865 | 1 | 110 | 154 | |
Testosterone and metabolites, Testosterone and metabolites, WADA PCC | 5β-Androstane-3α, 17β-diol-3-O-β-glucuronic acid |
S003 | 1 | 141 | 198 | |
WADA PCC | 7a-methyl-5b-estran-3a-ol-17-one |
S047 | 1 (ampoule) | 110 | 154 | |
WADA PCC, Nandrolone metabolites | 7a-methylnandrolone |
S048 | 1 mg | 110 | 154 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Value of 19-norandrosterone in freeze dried human urine * (d13CVPDB / ‰ –29.82 ± 0.41), Etiocholanolone (d13CVPDB / ‰ -23.60 ± 0.51), Androsterone (d13CVPDB / ‰ -22.27 ± 0.57), Testosterone (d13CVPDB / ‰ -27.48 ± 0.73), Epitestosterone (d13CVPDB / ‰ -23.74 ± 0.80), 5a-androstane-3a,17b-diol (d13CVPDB / ‰ -23.83 ± 0.90), 5b-androstane-3a,17b-diol (d13CVPDB / ‰ -23.76 ± 0.61), 11-oxoetiocholanolone (d13CVPDB / ‰ -22.23 ± 0.48), 11b-hydroxyandrosterone (d13CVPDB / ‰ -22.38 ± 0.64), Pregnanediol (d13CVPDB / ‰ -22.79 ± 0.77), 16-androstenol (d13CVPDB / ‰ -22.51 ± 0.60) |
MX017(ii) | See certificate | 360 | 504 | |
WADA PCC, Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon Isotope Delta Value of Boldenone* (d13CVPDB / ‰ –30.38 ± 0.29) |
MX020 | See certificate | 240 | 336 | |
WADA PCC, Steroid carbon isotope ratio standard mixture reference material for GCC-IRMS | Carbon Isotope Delta Value of Formestane* (d13CVPDB / ‰ –30.71 ± 0.48) |
MX021 | See certificate | 240 | 336 | |
WADA PCC | 7a-Methyl-estr-4-ene-3a-ol-17-one (WADA material) |
S050 | 1 mg | 110 | 154 | |
Steroids, Sports doping control, WADA PCC, 4-Hydroxy steroids | 1,6,7-d3-4-Hydroxyandrostendione |
S046 | 0.2 | 110 | 154 | |
WADA PCC, Steroid Matrix Reference Material | 19-Norandrosterone* (221.4 ng/g) in 1,2-dimethoxyethane (1 mL) |
MX003 | See certificate | 165 | 242 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Value of 19-norandrosterone in Water containing 20% Methanol 1 (mL) * d13CVPDB / ‰ –29.7 ± 0.8 |
MX016 | See certificate | 240 | 336 | |
WADA PCC, Steroid Matrix Reference Material | Mass fraction of testosterone metabolites in freeze dried human urine*: 5α-androstane-3α-17β-diol (41.2 ± 1.8 ng/g), 5β‑androstane-3α-17β-diol (66.0 ± 2.9 ng/g), androsterone 1652 ± 29 ng/g), etiocholanolone (1359 ± 34 ng/g), testosterone (88.1 ± 4.2 ng/g), epitestosterone (21.9 ± 1.0 ng/g), T/E mass ratio (4.03 ± 0.26) |
MX017(i) | See certificate | 360 | 504 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Values: |
MX018 | See certificate | 240 | 336 | |
WADA PCC, Steroid Matrix Reference Material | Carbon Isotope Delta Value of 19-norandrosterone in freeze dried human urine * (d13CVPDB / ‰ –29.82 ± 0.41), Etiocholanolone (d13CVPDB / ‰ -23.60 ± 0.51), Androsterone (d13CVPDB / ‰ -22.27 ± 0.57), Testosterone (d13CVPDB / ‰ -27.48 ± 0.73), Epitestosterone (d13CVPDB / ‰ -23.74 ± 0.80), 5a-androstane-3a,17b-diol (d13CVPDB / ‰ -23.83 ± 0.90), 5b-androstane-3a,17b-diol (d13CVPDB / ‰ -23.76 ± 0.61), 11-oxoetiocholanolone (d13CVPDB / ‰ -22.23 ± 0.48), 11b-hydroxyandrosterone (d13CVPDB / ‰ -22.38 ± 0.64), Pregnanediol (d13CVPDB / ‰ -22.79 ± 0.77), 16-androstenol (d13CVPDB / ‰ -22.51 ± 0.60) |
MX017(ii) | See certificate | 360 | 504 | |
WADA PCC, Anti-inflammatory metabolites | α-Hydroxycarprofen† |
D1072 | 5 | 110 | 154 | |
Nandrolone and metabolites, Nandrolone and metabolites, WADA PCC, Nandrolone and metabolites | Epinandrolone sulfate TEA salt |
D783 | 5 | 110 | 154 |
World Anti-Doping Authority and Partnership for Clean Competition funded reference materials
Our RMs have demonstrated homogeneity and stability. We take all care in storing and handling these materials.
We have provided the currently valid certification where we can.
Our reference materials are available globally through our international partners:
Certified reference materials
We produce certified reference materials (CRMs) with established metrological traceability to the SI unit for mass (kg). We report all purity values, stated as a mass fraction, with the associated uncertainty in the certificate of analysis.
Restrictions on issue
The production of these materials is funded by the World Anti-Doping Agency (WADA). These materials are only available to laboratories with WADA or International Olympic Committee accreditation or who has entered the WADA accreditation process. Non-WADA-accredited laboratories who wish to purchase these materials must seek approval from WADA and provide evidence of the approval to us.
Ampouled materials
For each ampouled reference material the product information sheet or certificate of analysis will state the mass of analyte dispensed into each ampoule. For reference materials with certified reference material status we will report the mass of analyte with an associated uncertainty.
Goods and Services Tax for Australian customers
The prices quoted don’t include the Goods and Services Tax (GST). We will add GST— currently set at 10%—to our tax invoices and adjustment notes when required.
Delivery fee
Delivery and handling fees apply for all orders and vary with destination. We will provide the rates when you order.